Hemodialysis Adequacy

Chronic Kidney Disease, Dialysis, & Transplantation

Volumn , Issue , 2005, Pages 405-428

  Leypoldt, John K ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953291808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0158-4.50024-0     Document Type: Chapter

References (150)

1. Owen WF, Madore F, Brenner BM An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors. Am J Kidney Dis 1996, 8:931-936.
2. Scribner BH Forward to the fourth edition. Replacement of Renal Function by Dialysis 1996, v-vi. Kluwer Academic, Dordrecht. C. Jacobs, C.M. Kjellstrand, K.M. Koch (Eds.).
3. Excerpts from the USRDS 2003 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003, 42(suppl 5):S1-S230. US Renal Data System.
4. Vanholder R, De Smet R, Glorieux G, et al. The European Uremic Toxin Work Group (EUTox): Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 2003, 63:1934-1943.
5. Eschbach JW, Adamson JW Anemia of end-stage renal disease (ESRD). Kidney Int 1985, 28:1-5.
6. Mawer EB, Taylor CM, Backhouse J, et al. Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency. Lancet 1973, 1:626-628.
7. Mahajan SK Zinc metabolism in uremia. Int J Artif Organs 1988, 11:223-228.
8. Golper TA, Ahmad S L-carnitine administration to hemodialysis patients: Has its time come?. Semin Dial 1992, 5:94-98.
9. Hull AR Predictors of the excessive mortality rates of dialysis patients in the United States. Curr Opin Nephrol Hypertens 1994, 3:286-291.
10. Santoro A Confounding factors in the assessment of delivered hemodialysis dose. Kidney Int 2000, 58(suppl 76):S19-S27.
11. Lowrie EG, Laird NM, Parker TF, Sargent JA Effect of the hemodialysis prescription of patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 1981, 305:1176-1181.
12. The National Cooperative Dialysis Study. Kidney Int 1983, 23(suppl 13):S1-S122.
13. Lowrie EG, Lew NL Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990, 15:458-482.
14. Acchiardo SR, Hatten KW, Ruvinsky MJ, et al. Inadequate dialysis increases gross mortality rate. ASAIO J 1992, 38:M282-M285.
15. Collins AJ, Ma JZ, Umen A, Keshaviah P Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994, 23:272-282.
16. Hakim RM, Breyer J, Ismail N, Schulman G Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994, 23:661-669.
17. Lowrie EG Chronic dialysis treatment: Clinical outcome and related processes of care. Am J Kidney Dis 1994, 24:255-266.
18. Parker TF, Husni L, Huang W, et al. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994, 23:670-680.
19. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996, 50:550-556.
20. Vanholder R, De Smet R, Lesaffer G P-Cresol: A toxin revealing many neglected but relevant aspects of uraemic toxicity. Nephrol Dial Transplant 1999, 19:2813-2815.
21. Lesaffer G, De Smet R, Lamiere N, et al. Intradialytic removal of protein-bound toxins: Role of solute characteristics and of dialyzer membrane. Nephrol Dial Transplant 2000, 15:50-57.
22. Tenkhoff H, Shilipetan G, Boen ST One year's experience with home peritoneal dialysis. Trans Am Soc Artif Intern Organs 1965, 11:11-14.
23. Tenkhoff H, Curtis FK Experience with maintenance peritoneal dialysis in the home. Trans Am Soc Artif Intern Organs 1970, 16:90-99.
24. Scribner BH Discussion. Trans Am Soc Artif Intern Organs 1965, 11:29.
25. Babb AL, Popovich RP, Christopher TG, Scribner BH The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 1971, 17:81-91.
26. Babb AL, Strand MJ, Uvelli DA, et al. Quantitative description of dialysis treatment: A dialysis index. Kidney Int Suppl 1975, 2:23-29.
27. Gotch FA, Sargent JA, Peters JH Studies on the molecular etiology of uremia. Kidney Int Suppl 1975, 3:276-279.
28. Lowrie EG, Steinberg SM, Galen MA, et al. Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia. Kidney Int 1976, 10:409-422.
29. van Ypersele de Strihou C, Jadoul M, Malghem J, et al. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int 1991, 39:1012-1019.
30. Koch KM Dialysis-related amyloidosis. Kidney Int 1992, 41:1416-1429.
31. 2-microglobulin-derived amyloidosis: An update. Kidney Int 2001, 59(suppl 78):S164-S171.
32. Attman PO, Alaupovic P Lipid abnormalities in chronic renal insufficiency. Kidney Int Suppl 1991, 31:S16-S23.
33. Seres DS, Strain GW, Hashim SA, et al. Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 1993, 3:1409-1415.
34. Wineman RJ Rationale of the National Cooperative Dialysis Study. Kidney Int 1983, 23(suppl 13):S8-S10.
35. Lowrie EG, Laird NM, Henry RR Protocol for the National Cooperative Dialysis Study. Kidney Int Suppl 1983, 13:S11-S18.
36. Sargent JA Control of dialysis by a single-pool urea model: The National Cooperative Dialysis Study. Kidney Int Suppl 1983, 13:S19-S25.
37. Parker TF, Laird NM, Lowrie EG Comparison of the study groups in the National Cooperative Dialysis Study and a description of morbidity, mortality, and patient withdrawal. Kidney Int Suppl 1983, 13:S42-S49.
38. Harter HR Review of significant findings from the National Cooperative Dialysis Study and recommendations. Kidney Int Suppl 1983, 13:S107-S112.
39. Laird NM, Berkey CS, Lowrie EG Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int Suppl 1983, 13:S101-S106.
40. Gotch FA Kinetic modeling in hemodialysis. Clinical Dialysis 1995, 156-188. Appleton & Lange, Norwalk, CT. A.R. Nissenson, R.N. Fine, D.E. Gentile (Eds.).
41. Gotch FA, Sargent JA A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985, 28:526-534.
42. US Renal Data System, USRDS 1998 Annual Data Report 1998, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
43. Tokars JI, Frank M, Alter MJ, Arduino MJ National surveillance of dialysis-associated diseases in the United States, 2000. Semin Dial 2002, 15:162-171.
44. Vanholder R, Van Loo A, Dhondt AM, et al. Second symposium on uraemic toxicity. Summary of a symposium held in Gent, Belgium, 22-24 September 1994. Nephrol Dial Transplant 1995, 10:414-418.
45. Brahm J Urea permeability of human red cells. J Gen Physiol 1983, 82:1-23.
46. Cheung AK, Alford MF, Wilson MM, et al. Urea movement across erythrocyte membrane during artificial kidney treatment. Kidney Int 1983, 23:866-869.
47. Owen WF, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993, 329:1001-1006.
48. Hume R, Weyers E Relationship between total body water and surface area in normal and obese subjects. J Clin Pathol 1971, 24:234-238.
49. Watson PE, Watson ID, Batt RD Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980, 33:27-39.
50. Chertow GM, Lazarus JM, Lew NL, et al. Development of a population-specific regression equation to estimate total body water in hemodialysis patients. Kidney Int 1997, 51:1578-1582.
51. Daugirdas JT, Greene T, Depner TA, et al. The Hemodialysis (HEMO) Study: Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender. Kidney Int 2003, 64:1108-1119.
52. Sargent J, Gotch F, Borah M, et al. Urea kinetics: A guide to nutritional management of renal failure. Am J Clin Nutr 1978, 31:1696-1702.
53. Sargent JA, Gotch FA Mathematic modeling of dialysis therapy. Kidney Int Suppl 1980, 10:S2-S10.
54. Renal Physician's Association: Clinical practice guideline working committee. In Clinical Practice Guideline on Adequacy of Hemodialysis. Clinical Practice Guideline, No. 1. Dubuque, IA, Kendall/Hunt, 1996.
55. K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, 2000. Am J Kidney Dis 2001, 37(suppl 1):S7-S64. National Kidney Foundation.
56. Flanigan MJ, Lim VS, Redlin J The significance of protein intake and catabolism. Adv Ren Replace Ther 1995, 2:330-340.
57. Owen WF Nutritional status and survival in end-stage renal disease patients. Miner Electrolyte Metab 1998, 24:72-81.
58. Keane WF, Collins AJ Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis 1994, 24:1010-1018.
59. Daugirdas JT Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993, 4:1205-1213.
60. Lowrie EG, Lew NL The urea reduction ratio (URR): A simple method for evaluating hemodialysis treatment. Contemp Dial Nephrol 1991, 1:11-19.
61. Daugirdas JT Rapid methods of estimating Kt/V: Three formulas compared. ASAIO Trans 1990, 36:M362-M364.
62. Flanigan MJ, Fangman J, Lim VS Quantitating hemodialysis: A comparison of three kinetic models. Am J Kidney Dis 1991, 17:295-302.
63. Daugirdas JT Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995, 2:295-304.
64. Depner TA Estimation of Kt/V from the urea reduction ratio for varying levels of dialytic weight loss: A bedside graphic aid. Semin Dial 1993, 6:242.
65. Sherman RA, Cody RP, Rogers ME, Solanchick JC Accuracy of the urea reduction ratio in predicting dialysis delivery. Kidney Int 1995, 47:319-321.
66. Basile C, Casino F, Lopez T Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. Am J Kidney Dis 1990, 15:40-45.
67. Jindal KK, Manuel A, Goldstein MB Percent reduction in blood urea concentration during hemodialysis (PRU). A simple and accurate method to estimate Kt/V urea. ASAIO Trans 1987, 33:286-288.
68. Daugirdas JT Linear estimates of variable-volume, single-pool Kt/V: An analysis of error. Am J Kidney Dis 1993, 22:267-270.
69. Garred LJ Dialysate-based kinetic modeling. Adv Ren Replace Ther 1995, 2:305-318.
70. Bankhead MM, Toto RD, Star RA Accuracy of urea removal estimated by kinetic models. Kidney Int 1995, 48:785-793.
71. Depner TA, Greene T, Gotch FA, et al. The Hemodialysis Study Group: Imprecision of the hemodialysis dose when measured directly from urea removal. Kidney Int 1999, 55:635-647.
72. Ing TS, Yu AW, Wong FK, et al. Collection of a representative fraction of total spent hemodialysate. Am J Kidney Dis 1995, 25:810-812.
73. Raj DS, Tobe S, Saiphoo C, Manuel MA Quantitating dialysis using two dialysate samples: A simple, practical and accurate approach for evaluating urea kinetics. Int J Artif Organs 1997, 20:422-427.
74. Depner TA, Keshaviah PR, Ebben JP, et al. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J Am Soc Nephrol 1996, 7:464-471.
75. Del Vecchio L, Di Filippo S, Andrulli S, et al. Conductivity: Online monitoring of dialysis adequacy. Int J Artif Organs 1998, 21:521-525.
76. Di Filippo S, Andrulli S, Manzoni C, et al. On-line assessment of delivered dialysis dose. Kidney Int 1998, 54:263-267.
77. Di Filippo S, Manzoni C, Andrulli S, et al. How to determine ionic dialysance for the online assessment of delivered dialysis dose. Kidney Int 2001, 59:774-782.
78. Kuhlmann U, Goldau R, Samadi N, et al. Accuracy and safety of online clearance monitoring based on conductivity variation. Nephrol Dial Transplant 2001, 16:1053-1058.
79. McIntyre CW, Lambie SH, Taal MW, Fluck RJ Assessment of hemodialysis adequacy by ionic dialysance: Intra-patient variability of delivered treatment. Nephrol Dial Transplant 2003, 18:559-562.
80. Schneditz D, Van Stone JC, Daugirdas JT A regional blood circulation alternative to in-series two compartment urea kinetic modeling. ASAIO J 1993, 29:M573-M577.
81. Daugirdas JT, Schneditz D Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 1995, 41:M719-M724.
82. Heineken FG, Evans MC, Keen ML, Gotch FA Intercompartmental fluid shifts in hemodialysis patients. Biotechnol Progr 1987, 3:69-73.
83. Cappello A, Grandi F, Lamberti C, Santoro A Comparative evaluation of different methods to estimate urea distribution volume and generation rate. Int J Artif Organs 1994, 17:322-330.
84. Daugirdas JT Bedside formulas for Kt/V. A kinder, gentler approach to urea kinetic modeling. ASAIO Trans 1989, 35:336-338.
85. Smye SW, Evans JH, Will E, Brocklebank JT Paediatric haemodialysis: Estimation of treatment efficiency in the presence of urea rebound. Clin Phys Physiol Meas 1992, 13:51-62.
86. Abramson F, Gibson S, Barlee V, Bosch JP Urea kinetic modeling at high urea clearances: Implications for clinical practice. Adv Ren Replace Ther 1994, 1:5-14.
87. Leblanc M, Charbonneau R, Lalumiere G, et al. Postdialysis urea rebound: Determinants and influence on dialysis delivery in chronic hemodialysis patients. Am J Kidney Dis 1996, 27:253-261.
88. Kaufman AM, Schneditz D, Smye S, et al. Solute disequilibrium and multicompartment modeling. Adv Ren Replace Ther 1995, 2:319-329.
89. Daugirdas JT Estimation of equilibrated Kt/V using unequilibrated postdialysis BUN. Semin Dial 1995, 8:283-284.
90. George TO, Priester-Coary A, Dunea G, et al. Cardiac output and urea kinetics in dialysis patients: Evidence supporting the regional blood flow model. Kidney Int 1996, 50:1273-1277.
91. Spiegel DM, Baker PL, Babcock S, et al. Hemodialysis urea rebound: The effect of increasing dialysis efficiency. Am J Kidney Dis 1995, 25:26-29.
92. Stegeman CA, Huisman RM, de Rouw B, et al. Determination of protein catabolic rate in patients on chronic intermittent hemodialysis: Urea output measurements compared with dietary protein intake and with calculation of urea generation rate. Am J Kidney Dis 1995, 25:887-895.
93. Tattersall JE, DeTakats D, Chamney P, et al. The post-hemodialysis rebound: Predicting and quantifying its effect on Kt/V. Kidney Int 1996, 50:2094-2102.
94. Smye SW, Tattersall JE, Will EJ Modeling the postdialysis rebound: The reconciliation of current formulas. ASAIO J 1999, 45:562-567.
95. Daugirdas JT, Depner TA, Gotch FA, et al. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997, 52:1395-1405.
96. Daugirdas JT, Greene T, Depner TA, et al. Factors affecting postdialysis rebound in serum urea concentrations, including the rate of dialysis: Results from the HEMO Study. J Am Soc Nephrol 2004, 15:194-203.
97. Sherman RA, Levy SS Rate-related recirculation: The effect of altering blood flow on dialyzer recirculation. Am J Kidney Dis 1991, 17:170-173.
98. Tattersall JE, Chamney P, Aldridge C, Greenwood RN Recirculation and the postdialysis rebound. Nephrol Dial Transplant 1996, 11(suppl 2):75-80.
99. Schneditz D, Kaufman AM, Polaschegg HD, et al. Cardiopulmonary recirculation during hemodialysis. Kidney Int 1992, 42:1450-1456.
100. Depner TA, Rizwan S, Cheer AY, et al. High venous urea concentrations in the opposite arm: A consequence of hemodialysis-induced compartment disequilibrium. ASAIO Trans 1991, 37:M141-M143.
101. Owen WF, Meyer KB, Schmidt G, Alfred H Methodological limitations of the ESRD Core Indicators Project: An ESRD network's experience with implementing an ESRD quality survey. Medical Review Board of the ESRD Network of New England. Am J Kidney Dis 1997, 30:349-355.
102. Depner TA, Cheer A Modeling urea kinetics with two vs. three BUN measurements. A critical comparison. ASAIO Trans 1989, 35:499-502.
103. Lai YH, Guh JY, Chen HC, Tsai JH Effects of different sampling methods for measurement of post dialysis blood urea nitrogen on urea kinetic modeling derived parameters in patients undergoing long-term hemodialysis. ASAIO J 1995, 41:211-215.
104. Sherman RA, Matera JJ, Novik L, Cody RP Recirculation reassessed: The impact of blood flow rate and the low-flow method reevaluated. Am J Kidney Dis 1994, 23:846-848.
105. Daugirdas JT, Burke MS, Balter P, et al. Screening for extreme postdialysis urea rebound using the Smye method: Patients with access recirculation identified when a slow flow method is not used to draw the postdialysis blood. Am J Kidney Dis 1996, 28:727-731.
106. Saha LK, Van Stone JC Differences between KT/V measured during dialysis and KT/V predicted from manufacturer clearance data. Int J Artif Organs 1992, 15:465-469.
107. Hornberger JC The hemodialysis prescription and quality-adjusted life expectancy. Renal Physicians Association Working Committee on Clinical Guidelines. J Am Soc Nephrol 1993, 4:1004-1020.
108. Beto JA, Bansal VK, Ing TS, Daugirdas JT Variation in blood sample collection for determination of hemodialysis adequacy. Council on Renal Nutrition National Research Question Collaborative Study Group. Am J Kidney Dis 1998, 31:135-141.
109. Hornberger JC The hemodialysis prescription and cost effectiveness. Renal Physicians Association Working Committee on Clinical Guidelines. J Am Soc Nephrol 1993, 4:1021-1027.
110. Lindsay RM, Henderson LW Adequacy of dialysis. Kidney Int Suppl 1988, 24:S92-S99.
111. Gotch FA, Levin NW, Port FK, et al. Clinical outcome relative to the dose of dialysis is not what you think: The fallacy of the mean. Am J Kidney Dis 1997, 30:1-15.
112. Delmez JA, Windus DW Hemodialysis prescription and delivery in a metropolitan community. The St. Louis Nephrology Study Group. Kidney Int 1992, 41:1023-1028.
113. Sargent JA Shortfalls in the delivery of dialysis. Am J Kidney Dis 1990, 15:500-510.
114. LeFebvre JM, Spanner E, Heidenheim AP, Lindsay RM Kt/V: Patients do not get what the physician prescribes. ASAIO Trans 1991, 37:M132-M133.
115. Sehgal AR, Snow RJ, Singer ME, et al. Barriers to adequate delivery of hemodialysis. Am J Kidney Dis 1998, 31:593-601.
116. Sherman RA, Cody RP, Solanchick JC Racial differences in the delivery of hemodialysis. Am J Kidney Dis 1993, 21:632-634.
117. Price DA, Owen WF African-Americans on maintenance dialysis: A review of racial differences in incidence, treatment, and survival. Adv Ren Replace Ther 1997, 4:3-12.
118. Owen WF, Chertow GM, Lazarus JM, Lowrie EG Dose of hemodialysis and survival: Differences by race and sex. JAMA 1998, 280:1764-1768.
119. Goldwasser P, Mittman N, Antignani A, et al. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993, 3:1613-1622.
120. McClellan WM, Soucie JM, Flanders WD Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis. J Am Soc Nephrol 1998, 9:1940-1947.
121. Kopple JD, Zhu X, Lew NL, Lowrie EG Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999, 56:1136-1148.
122. Chertow GM, Owen WF, Lazarus JM, et al. Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 1999, 56:1872-1878.
123. Capelli JP, Kushner H, Camiscioli T, et al. Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis times. Am J Nephrol 1992, 12:212-223.
124. Wolfe RA, Ashby VB, Daugirdas JT, et al. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 2000, 35:80-88.
125. Lowrie EG, Chertow GM, Lew NL, et al. The urea (clearance x dialysis time) product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int 1999, 56:729-737.
126. Lowrie EG, Li Z, Ofsthun N, Lazarus JM Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 2002, 62:1891-1897.
127. O'Conner AS, Leon JB, Sehgal AR The relative predictive ability of four different measures of hemodialysis dose. Am J Kidney Dis 2002, 40:1289-1294.
128. Held PJ, Levin NW, Bovbjerg RR, et al. Mortality and duration of hemodialysis treatment. JAMA 1991, 265:871-875.
129. Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992, 41:1286-1291.
130. Charra B, Calemard M, Laurent G Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996, 16:35-44.
131. Rozich JD, Smith B, Thomas JD, et al. Dialysis-induced alterations in left ventricular filling: Mechanisms and clinical significance. Am J Kidney Dis 1991, 17:277-285.
132. Skroeder NR, Jacobson SH, Lins LE, Kjellstrand CM Acute symptoms during and between hemodialysis: The relative role of speed, duration, and biocompatibility of dialysis. Artif Organs 1994, 18:880-887.
133. Rocco MV, Burkart JM Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol 1993, 4:1178-1183.
134. Kinet JP, Soyeur D, Balland N, et al. Hemodynamic study of hypotension during hemodialysis. Kidney Int 1982, 21:868-876.
135. Jahn H, Schohn D, Schmitt R Hemodynamic modifications induced by fluid removal and treatment modalities in chronic hemodialysis patients. Blood Purif 1983, 1:80-89.
136. de Vries JP, Kouw PM, van der Meer NJ, et al. Non-invasive monitoring of blood volume during hemodialysis: Its relation with post-dialytic dry weight. Kidney Int 1993, 44:851-854.
137. De Vries JP, Bogaard HJ, Kouw PM, et al. The adjustment of post dialytic dry weight based on non-invasive measurement of extracellular fluid and blood volumes. ASAIO J 1993, 39:M368-M372.
138. Fishbane S, Natke E, Maesaka JK Role of volume overload in dialysis-refractory hypertension. Am J Kidney Dis 1996, 28:257-261.
139. Sulkova S, Valek A Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment. Kidney Int Suppl 1988, 25:S198-S200.
140. Leypoldt JK, Cheung AK, Carroll CE, et al. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 1999, 33:349-355.
141. 2-microglobulin clearance during hemodialysis. ASAIO J 1997, 43:904-909.
142. 2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol 1999, 10:117-127.
143. 2-microglobulin after hemodialysis. Kidney Int 1999, 56:1571-1577.
144. Eknoyan G, Levey AS, Beck GJ, et al. The HEMO Study Group: The Hemodialysis (HEMO) Study: Rationale for selection of interventions. Semin Dial 1996, 9:24-33.
145. Eknoyan G, Beck GJ, Cheung AK, et al. The Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002, 347:2010-2019.
146. Cheung AK, Levin NW, Greene T, et al. Effects of high-flux hemodialysis on clinical outomes: Results of the HEMO Study. J Am Soc Nephrol 2003, 14:3251-3263.
147. Depner T, Daugirdas J, Greene T, et al: The Hemodialysis (HEMO) Study Group: Effect of gender and body size on outcome in the HEMO Study. 2004 (In review).
148. European Best Practice Guidelines for Haemodialysis (Part 1). Nephrol Dial Transplant 2002, 17(suppl 7):1-109.
149. Fagugli RM, De Smet R, Buoncristiani U, et al. Behavior of non-protein bound and protein-bound uremic solute during daily hemodialysis. Am J Kidney Dis 2002, 40:339-347.
150. Gotch FA The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998, 13(suppl 6):10-14.